Amy S Piatek
Overview
Explore the profile of Amy S Piatek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piatek A, Wells W, Shen K, Colvin C
Glob Health Sci Pract
. 2019 Dec;
7(4):551-563.
PMID: 31818871
The potential gains from full adoption of World Health Organization (WHO)-recommended rapid diagnostics (WRDs) for tuberculosis (TB) are significant, but there is no current analysis of the additional investment needed...
2.
Law S, Piatek A, Vincent C, Oxlade O, Menzies D
Lancet Public Health
. 2017 Dec;
2(1):e47-e55.
PMID: 29249480
Background: India has the highest number of patients with tuberculosis and multidrug-resistant tuberculosis in the world. We used a transmission model to project the emergence of drug resistance in India...
3.
Pathmanathan I, Date A, Coggin W, Nkengasong J, Piatek A, Alexander H
Afr J Lab Med
. 2017 Aug;
6(2).
PMID: 28785533
Background: To eliminate preventable deaths, disease and suffering due to tuberculosis (TB), improved diagnostic capacity is critical. The Cepheid Xpert MTB/RIF assay is recommended by the World Health Organization as...
4.
Piatek A, Van Cleeff M, Alexander H, Coggin W, Rehr M, van Kampen S, et al.
Glob Health Sci Pract
. 2014 Oct;
1(1):18-23.
PMID: 25276513
Xpert MTB/RIF is a major advance for TB diagnostics, especially for multidrug-resistant (MDR) TB and HIV-associated TB. But implementation concerns including cost, technical support requirements, and challenging demands of providing...
5.
Schito M, Peter T, Cavanaugh S, Piatek A, Young G, Alexander H, et al.
J Infect Dis
. 2012 Mar;
205 Suppl 2:S169-80.
PMID: 22457286
Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to...
6.
Slopen M, Laraque F, Piatek A, Ahuja S
J Public Health Manag Pract
. 2011 Jul;
17(5):421-6.
PMID: 21788779
Background: Proper management and prevention can radically decrease the incidence of tuberculosis (TB). To further decrease TB cases in New York City, every opportunity for prevention must be utilized. This...
7.
Clark C, Driver C, Munsiff S, Driscoll J, Kreiswirth B, Zhao B, et al.
Emerg Infect Dis
. 2006 May;
12(5):719-24.
PMID: 16704826
In 2001, New York City implemented genotyping to its tuberculosis (TB) control activities by using IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping to type isolates from culture-positive TB patients....